Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Diagnostic Alliance for Colon Cancer

By HospiMedica staff writers
Posted on 06 Feb 2001

A Research Support Agreement (RSA) in the field of colon cancer diagnostics has been announced by Fox Chase Cancer Center (Philadelphia, PA, USA) and Immunicon Corp. More...
(Huntingdon Valley, PA, USA).

The RSA is for two years and provides monetary support for research into applications and further development of Immunicon's rare-cell detection and analysis technologies for the screening, diagnosis, and monitoring of patients with colon cancer. A main goal of the research will be to identify unique biologic targets or markers of clinical interest on the surface of and within tumor cells circulating in the blood of colon cancer patients.

Subject to regulatory approvals and other requirements, Advanced Diagnostic Systems, a newly formed division of Ortho-Clinical Diagnostics (OCD), will market exclusively any diagnostic products developed by Immunicon in the human cancer field. Immunicon announced the signing of a development, license, and supply agreement with OCD in September 2000.

"This association holds the promise for developing entirely new techniques for screening, diagnosing, staging, and monitoring colorectal cancer,” said Louis Weiner, M.D., chairman of the department of medical oncology at Fox Chase Cancer Center.



Related Links:
Fox Chase Cancer Center

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
X-Ray Generator
Advantage Plus Generators
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.